Abstract 380 TableĀ 1
1st author, yearControlProphylaxis Group% of VTE in Anticoag% VTE in controlP valueAny other serious side-effects of anticoagulant drugsWas patient discontinued due to side effectsDuration on prophylaxisFollow-up period
Ruud, 2007No prophylaxis (n=33)warfarin (n=29)14/29 (48%)12/33 (36%)p=0.44Most thrombi were transientyes (n=11)>6 mos1,3,6 mos
Elhasid, 2001Matched historical controls (n=50)LMWH (n=27)1/41 (2.4%)2/50 (10%)p<0.051 patient LMWH had brain infarctno6 mos1,3,6 mos
Massicottea, 2003No prophylaxis (n=80)LMWH (n=92)11/78 (14.1%)10/80 (12.5%)p=0.41Bleeding, 2 deaths in controlno; 15%(n=28) were not evaluable30 days2 weeks
Meister, 2008Historical controls who got Antithrombin only (n=71)LMWH and Antithrombin (n=41)0/41 (0%)9/71 (12.7%)p=0.02nono45 days240 days